LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Mayo Hip Dislocation Risk Calculator Unveiled
Large Joints and Extremities

Mayo Hip Dislocation Risk Calculator Unveiled

July 13, 2022 2 min read Premium comments

Advertisement

#totalhiparthroplastySecondary#dislocationriskcalculator

New work, based on two decades of data from Mayo Clinic in Rochester, Minnesota (“Creation of a Total Hip Arthroplasty Patient-Specific Dislocation Risk Calculator”) has found that risk at the individual patient level can be successfully calculated using an unusually comprehensive screening tool. The study appears in the June 15, 2022, edition of The Journal of Bone and Joint Surgery.

Describing their calculator as a “high-dimensional, patient-specific risk prediction model for dislocation following THA [total hip arthroplasty] that allows for dynamic risk modification based on operative decisions,” the researchers looked at 29,349 THAs (21,978 primary and 7,371 revision cases) performed over two decades between 1998 and 2018.

Drilling down, the Mayo team was able to create a risk prediction model using a wide range of variables and that can be adapted to decisions within the surgeon’s control. Specifically, they examined “instability comorbidities” such as neurologic disease, spine disease, and spine surgery.

The paper’s first author, Cody Wyles, M.D., told OTW, “Despite many advances, dislocation remains the most common complication after THA and is one of the most common reasons for revision surgery.”

“Intuitively, surgeons know that patients have different baseline risks for dislocation and that surgical factors such as approach, head size, and liner type can modulate this risk. However, no tool previously existed to quantify a patient’s baseline risk and the degree to which the risk is changed by different surgical decisions.”

“Our tool is the first to provide this knowledge so that surgeons can make informed patient-specific choices to manage the most prevalent complication of THA.”

Power to the Surgeon

“We found that baseline risk was extremely wide-ranging, from 0.3%-3.0% at 1 year and from 0.4%-19.0% at 5 years after primary THA, and from 2.0%-32.0% at 1 year and from 3.0%-42.0% at 5 years after revision THA.”

Advertisement

“Despite these grim and humbling statistics, the second primary message of the paper is hopeful. That is, surgeons have enormous power to modify risk. Surgical approach, femoral head size, and acetabular liner type are the most influential factors in the model, meaning that surgeons can do a great deal to manage risk.”

“We further identified that in the revision setting, acetabular revision independently decreased risk by 40%. We would encourage readers to consult the Tables and Figures in the manuscript for details of the risk reduction for each variable.”

“There are very few databases that have the detail, longitudinal follow-up, and complete capture of postoperative outcomes to conduct a study of this sort. The most important variable here is the capture of postoperative outcomes.”

“Even some of the most complete registries only capture revision for dislocation, yet that constitutes the minority of this complication. We are fortunate that the Mayo total joint registry captures all dislocations even if they occur outside of our health system.”

“This tool is the first of its kind to quantify patient-specific baseline risk and the degree to which risk is modulated by decisions within a surgeon’s control. As a preoperative tool, this will enable surgeons to screen for high-risk patients and determine which patients would benefit from alternative intraoperative management.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy